Skip to main content
Breast Cancer Research : BCR logoLink to Breast Cancer Research : BCR
. 2024 Apr 2;26:58. doi: 10.1186/s13058-024-01811-y

Correction: Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

Muhammad Hasan Bashari 1,2, Fengjuan Fan 1, Sonia Vallet 1, Martin Sattler 3, Melissa Arn 4, Claudia Luckner-Minden 1,5, Henning Schulze-Bergkamen 1, Inka Zörnig 1,5, Frederik Marme 1, Andreas Schneeweiss 1, Michael H Cardone 4, Joseph T Opferman 6, Dirk Jäger 1,5, Klaus Podar 1,
PMCID: PMC10988845  PMID: 38566222

Correction: Breast Cancer Research (2016) 18:26 10.1186/s13058-016-0686-4

Following the publication of the original article [1], the author reported that PARP blots of JIMT-1 and JIMT-1-BR3 cells in Fig. 7C of the original publication were mistakenly duplicated.

Error image graphic file with name 13058_2024_1811_Figa_HTML.jpg

The correct figure below depicts the correct PARP blot for JIMT-1 cells.

Correct image graphic file with name 13058_2024_1811_Figb_HTML.jpg

The error does not affect any of the interpretations or conclusions of the article.

The email address of the Corresponding Author has also been updated, from klaus.podar@nct-heidelberg.de to klaus.podar@krems.lknoe.at as shown in this Correction article.

The original article [1] has been updated.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Bashari MH, Fan F, Vallet S, et al. Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications. Breast Cancer Res. 2016;18:26. doi: 10.1186/s13058-016-0686-4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Breast Cancer Research : BCR are provided here courtesy of BMC

RESOURCES